At a glance
- Originator Pfizer
- Class Antihypertensives; Dioxoles; Small molecules
- Mechanism of Action Endothelin A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 23 Feb 2001 No-Development-Reported for Hypertension in USA (PO)
- 23 Jun 2000 Warner-Lambert has merged with Pfizer
- 03 Jul 1995 New profile